Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
Clinical trial NCT00816283 · COMPLETED
Trial details
- NCT number
- NCT00816283
- Sponsor
- City of Hope Medical Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-06-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.